NFATC2 and breast adenocarcinoma: Current annotations of 2RQ, 7 PA, and 7PL missense mutations within the NFATc2 PxIxIT site recovered from sequenced lung and breast adenocarcinomas describe them as unlikely to have functional effects in vivo (cBioPortal, 2018).